FTC, drugstores sue Solvay over delay in generic AndroGel.

The AndroGel suits allege Solvay conspired with the generic defendants to monopolize the market. The generic manufacturers agreed to keep their product off the market for nearly a decade in exchange for substantial cash payments, the suits claim. As a result of the defendants’ illegal conduct, the suits suggested, plaintiffs paid artificially inflated prices for AndroGel and were deprived of the opportunity to purchase lower-priced generic versions of the medication.

With the huge profits involved in the 'legal' prescription HRT market it wouldn't surprise me to find that there were lobbyists employed by pharmaceutical companies doing their best to make sure steroids are not decriminalized.